Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Functional Foods
  4. Volume 2, Issue 2
  5. Article
Volume 2, Issue 2
  • ISSN: 2666-8629
  • E-ISSN: 2666-8637

Abstract

Background

Piperine, an active constituent isolated from and which is used to cure a variety of ailments related to lung, stomach, colon, skin . like Alzheimer’s, Parkinson’s disease, ulcerative colitis, cancer, arthritis, inflammatory bowel diseases, diabetes .

Objective

The objective of the review is to study the synergistic effect of piperine specially in cancer.

Methods

Patents and current literature mainly emphasizing the synergistic effect of piperine along with other drugs, especially anticancer drugs was reviewed keeping in mind the scientific novelty and impact.

Results

Several synergistic combinations of piperine were explored which can be beneficial for the pharmaceutical industry.

Conclusion

This review will assist the researchers in the preparation of novel formulations with improved efficacy cutting the cost of developing new drug molecules.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cff/10.2174/2666862901666230727104158
2023-09-23
2025-04-24

  • From This Site

    /content/journals/cff/10.2174/2666862901666230727104158
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. KeithC.T. BorisyA.A. StockwellB.R. Multicomponent therapeutics for networked systems.Nat. Rev. Drug Discov.200541717810.1038/nrd160915688074
     [Google Scholar]
  2. FoucquierJ. GuedjM. Analysis of drug combinations: Current methodological landscape.Pharmacol. Res. Perspect.201533e0014910.1002/prp2.14926171228
     [Google Scholar]
  3. PodolskyS.H. GreeneJ.A. Combination drugs--hype, harm, and hope.N. Engl. J. Med.2011365648849110.1056/NEJMp110616121830965
     [Google Scholar]
  4. MokT.S.K. KimS.W. WuY.L. Gefitinib plus chemotherapy versus chemotherapy in epidermal growth factor receptor mutation–positive non–small-cell lung cancer resistant to first-line gefitinib (impress): Overall survival and biomarker analyses.J. Clin. Oncol.201735364027403410.1200/JCO.2017.73.925028968167
     [Google Scholar]
  5. YangJ.C.H. MokT. HanB. OrlandoM. PuriT. ParkK. A review of regimens combining pemetrexed with an epidermal growth factor receptor tyrosine kinase inhibitor in the treatment of advanced nonsquamous Non-Small-Cell Lung cancer.Clin. Lung Cancer2018191273410.1016/j.cllc.2017.06.01328743421
     [Google Scholar]
  6. García-FuenteA. VázquezF. ViéitezJ.M. García AlonsoF.J. MartínJ.I. FerrerJ. CISNE: An accurate description of dose-effect and synergism in combination therapies.Sci. Rep.201881496410.1038/s41598‑018‑23321‑629563526
     [Google Scholar]
  7. TiwariA. MahadikK.R. GabheS.Y. Piperine: A comprehensive review of methods of isolation, purification and biological properties.Med. in Drug Dis2020100027
     [Google Scholar]
  8. Shanxi Huatai Pharmaceutical Co Ltd. Extraction method and application of piperine.Patent CN 103483309A, 2017.2017
  9. PatronA NonkowiczJ AngerT DavisJR FordsinC PresterC Compounds useful as TRPM8 modulators.patent CN108473484B, 2021.2021
  10. QaziGN BediLA JohriKR Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof. Patent US7514105B22006
  11. HaqI.U. ImranM. NadeemM. TufailT. GondalT.A. MubarakM.S. Piperine: A review of its biological effects.Phytother. Res.202135268070010.1002/ptr.685532929825
     [Google Scholar]
  12. GorganiL. MohammadiM. NajafpourG.D. NikzadM. Piperine-The bioactive compound of black pepper: From isolation to medicinal formulations.Compr. Rev. Food Sci. Food Saf.201716112414010.1111/1541‑4337.1224633371546
     [Google Scholar]
  13. RatherR.A. BhagatM. Cancer chemoprevention and piperine: Molecular mechanisms and therapeutic opportunities.Front. Cell Dev. Biol.201861010.3389/fcell.2018.0001029497610
     [Google Scholar]
  14. MotiwalaMN RangariVD combined effect of paclitaxel and piperine on a MCF-7 breast cancer cell line in vitro: Evidence of a synergistic interaction.Synres201516
     [Google Scholar]
  15. Pushpa RaginiS. Naga DivyaA.V. AnushaC.H. KanthaiahY.V. Enhancement of paclitaxel and doxorubicin cytotoxicity in breast cancer cell lines in combination with piperine treatment and analysis of expression of autography and apoptosis genes.J Med Sci Res201426267
     [Google Scholar]
  16. TalibW. Regressions of breast carcinoma syngraft following treatment with piperine in combination with thymoquinone.Sci. Pharm.20178532710.3390/scipharm8503002728671634
     [Google Scholar]
  17. StojanovicZ. PejcicM. AleksicA. KumarA. Piperine-a major principle of black pepper: A review of its bioactivity and studies.App Sci20199427010.3390/app9204270
     [Google Scholar]
  18. MinX JiaL HaoyangY JunqiW. 4, 5-disubstituted piperine derivatives, and preparation method and application thereof.Patent CN111592520A,2020
  19. WangY.H. Morris-NatschkeS.L. YangJ. NiuH.M. LongC.L. LeeK.H. Anticancer principles from medicinal piper (hú jiāo) plants.J. Tradit. Complement. Med.20144181610.4103/2225‑4110.12481124872928
     [Google Scholar]
  20. BhardwajR.K. GlaeserH. BecquemontL. KlotzU. GuptaS.K. FrommM.F. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4.J. Pharmacol. Exp. Ther.2002302264565010.1124/jpet.102.03472812130727
     [Google Scholar]
  21. ManayiA. NabaviS.M. SetzerW.N. JafariS. Piperine as a potential anti-cancer agent: A review on preclinical studies.Curr. Med. Chem.201925374918492810.2174/092986732466617052312065628545378
     [Google Scholar]
  22. ThielA. BuskensC. WoehrleT. Black pepper constituent piperine: Genotoxicity studies in vitro and in vivo.Food Chem. Toxicol.20146635035710.1016/j.fct.2014.01.05624525095
     [Google Scholar]
  23. YueG YuguangW DonghuaH Novel medicinal application of piperine.Patent CN103690537A2014
  24. ArlertA KrugerA RageC PizzarR Use of piperine and its derivatives for the treatment of neurological conditions.Patent JP2010531857A2010
  25. ChavarriaD. SilvaT. Magalhães e SilvaD. RemiãoF. BorgesF. Lessons from black pepper: Piperine and derivatives thereof.Expert Opin Pat201626245264
     [Google Scholar]
  26. ChintaG. SyedB.S. CoumarS.M. PeriyasamyL. Piperine: A comprehensive review of preclinical and clinical investigations.Curr. Bioact. Compd.201511315616910.2174/1573407211666150915214425
     [Google Scholar]
  27. LiN. WenS. ChenG. WangS. Antiproliferative potential of piperine and curcumin in drug-resistant human leukemia cancer cells are mediated via autophagy and apoptosis induction, s-phase cell cycle arrest and inhibition of cell invasion and migration.J. BUON202025140140632277661
     [Google Scholar]
  28. TripathiA.K. RayA.K. MishraS.K. Molecular and pharmacological aspects of piperine as a potential molecule for disease prevention and management: Evidence from clinical trials.Beni. Suef Univ. J. Basic Appl. Sci.20221111610.1186/s43088‑022‑00196‑135127957
     [Google Scholar]
  29. SelvarajJ. AnitaM. JayamathiG. Molecular docking analysis of piperine with cdk2, cdk4, cyclin d and cyclin t proteins.Bioinformation202016535936210.6026/9732063001635932831516
     [Google Scholar]
  30. GrineviciusV.M.A.S. AndradeK.S. MotaN.S.R.S. CDK2 and Bcl-xL inhibitory mechanisms by docking simulations and anti-tumor activity from piperine enriched supercritical extract.Food Chem. Toxicol.201913211064410.1016/j.fct.2019.11064431252023
     [Google Scholar]
  31. ChoiY. YuA.M. ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.Curr. Pharm. Des.201420579380710.2174/13816128200514021416521223688078
     [Google Scholar]
  32. GameiroM. SilvaR. Rocha-PereiraC. Cellular models and in vitro assays for the screening of modulators of P-gp, MRP1 and BCRP.Molecules201722460010.3390/molecules2204060028397762
     [Google Scholar]
  33. LiS. LeiY. JiaY. LiN. WinkM. MaY. Piperine, a piperidine alkaloid from piper nigrum re-sensitizes p-gp, mrp1 and bcrp dependent multidrug resistant cancer cells.Phytomedicine2011191838710.1016/j.phymed.2011.06.03121802927
     [Google Scholar]
  34. SyedS.B. AryaH. FuI.H. Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer.Sci. Rep.201771797210.1038/s41598‑017‑08062‑228801675
     [Google Scholar]
  35. GeorgeK. ThomasN.S. MalathiR. Piperine blocks voltage gated K+ current and inhibits proliferation in androgen sensitive and insensitive human prostate cancer cell lines.Arch. Biochem. Biophys.2019667364810.1016/j.abb.2019.04.00731047869
     [Google Scholar]
  36. ZengY. YangY. Piperine depresses the migration progression via downregulating the Akt/mTOR/MMP 9 signaling pathway in DU145 cells.Mol. Med. Rep.20181756363637010.3892/mmr.2018.865329488612
     [Google Scholar]
  37. MihaylovaM.M. ShawR.J. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism.Nat. Cell Biol.20111391016102310.1038/ncb232921892142
     [Google Scholar]
  38. PengX. YangT. LiuG. LiuH. PengY. HeL. Piperine ameliorated lupus nephritis by targeting AMPK-mediated activation of NLRP3 inflammasome.Int. Immunopharmacol.20186544845710.1016/j.intimp.2018.10.02530388519
     [Google Scholar]
  39. Sadri NahandJ. Bokharaei-SalimF. SalmaninejadA. microRNAs: Key players in virus‐associated hepatocellular carcinoma.J. Cell. Physiol.20192348121881222510.1002/jcp.2795630536673
     [Google Scholar]
  40. YangR. GaoN. ChangQ. MengX. WangW. The role of IDO, IL‐10, and TGF‐β in the HCV‐associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.J. Med. Virol.201991226527110.1002/jmv.2508329611873
     [Google Scholar]
  41. HuangH. Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: Recent advances.Sensors20181810324910.3390/s1810324930262739
     [Google Scholar]
  42. HwangY.P. YunH.J. KimH.G. Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by piperine via the inhibition of PKCα/ERK1/2-dependent matrix metalloproteinase-9 expression.Toxicol. Lett.2011203191910.1016/j.toxlet.2011.02.01321354279
     [Google Scholar]
  43. JananiC. Ranjitha KumariB.D. PPAR gamma gene – A review.Diabetes Metab. Syndr.201591465010.1016/j.dsx.2014.09.01525450819
     [Google Scholar]
  44. ParkU.H. JeongH.S. JoE.Y. Piperine, a component of black pepper, inhibits adipogenesis by antagonizing PPARγ activity in 3T3-L1 cells.J. Agric. Food Chem.201260153853386010.1021/jf204514a22463744
     [Google Scholar]
  45. PradeepC.R. KuttanG. Piperine is a potent inhibitor of nuclear factor-κB (NF-κB), c-Fos, CREB, ATF-2 and proinflammatory cytokine gene expression in B16F-10 melanoma cells.Int. Immunopharmacol.20044141795180310.1016/j.intimp.2004.08.00515531295
     [Google Scholar]
  46. RenC. LiangZ. RETRACTED: Piperine alleviates lipopolysaccharide-induced inflammatory injury by down-regulating microRNA-127 in murine chondrogenic ATDC5 cells.Biomed. Pharmacother.201810394795410.1016/j.biopha.2018.04.10829710511
     [Google Scholar]
  47. SiL. YangR. LinR. YangS. Piperine functions as a tumor suppressor for human ovarian tumor growth via activation of JNK/p38 MAPK-mediated intrinsic apoptotic pathway.Biosci. Rep.2018383BSR2018050310.1042/BSR2018050329717031
     [Google Scholar]
  48. TawaniA. AmanullahA. MishraA. KumarA. Evidences for Piperine inhibiting cancer by targeting human G-quadruplex DNA sequences.Sci. Rep.2016613923910.1038/srep3923927995955
     [Google Scholar]
  49. de AlmeidaG.C. OliveiraL.F.S. PredesD. Piperine suppresses the Wnt/β-catenin pathway and has anti-cancer effects on colorectal cancer cells.Sci. Rep.20201011168110.1038/s41598‑020‑68574‑2
     [Google Scholar]
  50. KhamisA.A.A. AliE.M.M. EL-Moneim MAA, Abd-Alhaseeb MM, EL-Magd MA, Salim EI. Hesperdine, piperine and bee venom synergistically potentiate the anticancer effect of tamoxifen against breast cancer cells.Biomed. Pharmacother.20181051335134310.1016/j.biopha.2018.06.10530021371
     [Google Scholar]
  51. KumarV. MittalV. JalwalP. Role of herbal bioenhancers (Piperine and Curcumin) on the oral bioavailability of Tamoxifen using experimental rats.J. Pharmacogn. Phytochem.201542133136
     [Google Scholar]
  52. KatiyarS.S. MuntimaduguE. RafeeqiT.A. DombA.J. KhanW. Co-delivery of rapamycin: And piperine-loaded polymeric nanoparticles for breast cancer treatment.Drug Deliv.20162372608261610.3109/10717544.2015.103966726036652
     [Google Scholar]
  53. FattahA. MorovatiA. NiknamZ. The Synergistic combination of cisplatin and piperine induces apoptosis in MCF-7 cell line.Iran. J. Public Health20215051037104710.18502/ijph.v50i5.612134183962
     [Google Scholar]
  54. BurandeA.S. ViswanadhM.K. JhaA. EGFR targeted paclitaxel and piperine co-loaded liposomes for the treatment of triple negative breast cancer.AAPS PharmSciTech202021112
     [Google Scholar]
  55. KakaralaM. BrennerD.E. KorkayaH. Targeting breast stem cells with the cancer preventive compounds curcumin and piperine.Breast Cancer Res. Treat.2010122377778510.1007/s10549‑009‑0612‑x19898931
     [Google Scholar]
  56. XieZ. WeiY. XuJ. LeiJ. YuJ. Alkaloids from piper nigrum synergistically enhanced the effect of paclitaxel against paclitaxel-resistant cervical cancer cells through the downregulation of Mcl-1.J. Agric. Food Chem.201967185159516810.1021/acs.jafc.9b0132031006247
     [Google Scholar]
  57. AbdelhamedS. YokoyamaS. RefaatA. Piperine enhances the efficacy of TRAIL-based therapy for triple-negative breast cancer cells.Anticancer Res.20143441893189924692724
     [Google Scholar]
  58. JeongS. JungS. ParkG.S. ShinJ. OhJ.W. Piperine synergistically enhances the effect of temozolomide against temozolomide-resistant human glioma cell lines.Bioengineered202011179180010.1080/21655979.2020.179410032693671
     [Google Scholar]
  59. SinghA. ThotakuraN. SinghB. Delivery of docetaxel to brain employing piperine-tagged PLGA-aspartic acid polymeric micelles: Improved cytotoxic and pharmacokinetic profiles.AAPS PharmSciTech201920622010.1208/s12249‑019‑1426‑831201588
     [Google Scholar]
  60. SrivastavaS. DewanganJ. MishraS. Piperine and celecoxib synergistically inhibit colon cancer cell proliferation via modulating wnt/β-catenin signaling pathway.Phytomedicine20218415348410.1016/j.phymed.2021.15348433667839
     [Google Scholar]
  61. BolatZ.B. IslekZ. DemirB.N. YilmazE.N. SahinF. UcisikM.H. Curcumin- and piperine-loaded emulsomes as combinational treatment approach enhance the anticancer activity of curcumin on hct116 colorectal cancer model.Front. Bioeng. Biotechnol.202085010.3389/fbioe.2020.0005032117930
     [Google Scholar]
  62. LambertJ.D. HongJ. KimD.H. MishinV.M. YangC.S. Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice.J. Nutr.200413481948195210.1093/jn/134.8.194815284381
     [Google Scholar]
  63. DasS. BeraD. PalK. Guar gum micro-vehicle mediated delivery strategy and synergistic activity of thymoquinone and piperine: An in vitro study on bacterial and hepatocellular carcinoma cells.J. Drug Deliv. Sci. Technol.20206010199410.1016/j.jddst.2020.101994
     [Google Scholar]
  64. PalM.K. JaiswarS.P. SrivastavA.K. Synergistic effect of piperine and paclitaxel on cell fate via cyt-c, Bax/Bcl-2-caspase-3 pathway in ovarian adenocarcinomas SKOV-3 cells.Eur. J. Pharmacol.201679175176210.1016/j.ejphar.2016.10.01927756602
     [Google Scholar]
  65. QiuM. XueC. ZhangL. Piperine alkaloid induces anticancer and apoptotic effects in cisplatin resistant ovarian carcinoma by inducing G2/M phase cell cycle arrest, caspase activation and inhibition of cell migration and PI3K/Akt/GSK3β signalling pathway.J. BUON20192462316232131983100
     [Google Scholar]
  66. DingY. DingY. WangY. Soluplus ®/TPGS mixed micelles for co-delivery of docetaxel and piperine for combination cancer therapy.Pharm. Dev. Technol.202025110711510.1080/10837450.2019.167983431603017
     [Google Scholar]
  67. BiswasS. KarA. SharmaN. HaldarP.K. MukherjeeP.K. Synergistic effect of ursolic acid and piperine in CCl 4 induced hepatotoxicity.Ann. Med.20215312009201710.1080/07853890.2021.199562534751064
     [Google Scholar]
  68. MakhovP. GolovineK. CanterD. Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity.Prostate201272666166710.1002/pros.2146921796656
     [Google Scholar]
  69. LiC. WangZ. WangQ. Enhanced anti-tumor efficacy and mechanisms associated with docetaxel-piperine combination- in vitro and in vivo investigation using a taxane-resistant prostate cancer model.Oncotarget2018933338335210.18632/oncotarget.2323529423050
     [Google Scholar]
  70. BaY. MalhotraA. Potential of piperine in modulation of voltage-gated K+ current and its influences on cell cycle arrest and apoptosis in human prostate cancer cells.Eur. Rev. Med. Pharmacol. Sci.201822248999901130575945
     [Google Scholar]
  71. SoE.C. WuS.N. WuP.C. ChenH.Z. YangC.J. Synergistic inhibition of delayed rectifier k+ and voltage-gated na+ currents by artemisinin in pituitary tumor (gh3) cells.Cell. Physiol. Biochem.20174152053206610.1159/00047543628456794
     [Google Scholar]
  72. MhaskeD.B. SreedharanS. MahadikK.R. Role of piperine as an effective bioenhancer in drug absorption.Pharm. Anal. Acta20189714
     [Google Scholar]
  73. BermanA.Y. MotechinR.A. WiesenfeldM.Y. HolzM.K. The therapeutic potential of resveratrol: A review of clinical trials.NPJ Precis. Oncol.2017113510.1038/s41698‑017‑0038‑628989978
     [Google Scholar]
  74. AggarwalB.B. BhardwajA. AggarwalR.S. SeeramN.P. ShishodiaS. TakadaY. Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies.Anticancer Res.2004245A2783284015517885
     [Google Scholar]
  75. JohnsonJ.J. NihalM. SiddiquiI.A. Enhancing the bioavailability of resveratrol by combining it with piperine.Mol. Nutr. Food Res.20115581169117610.1002/mnfr.20110011721714124
     [Google Scholar]
  76. PatilU.K. SinghA. ChakrabortyA.K. Role of piperine as a bioavailability enhancer.Int J Recent Adv Pharm Res201141623
     [Google Scholar]
  77. ThammineniN. Vara LakshmiM. Nandaki NagK. Studying whether curcumin and piperine sensitize breast cancer cells and breast cancer- initiating cells to radiations.Int. J. Radiat. Oncol. Biol. Phys.2014901S24610.1016/j.ijrobp.2014.05.868
     [Google Scholar]
  78. GuoL. YangY. ShengY. WangJ. RuanS. HanC. Mechanism of piperine in affecting apoptosis and proliferation of gastric cancer cells via ROS‐mitochondria‐associated signalling pathway.J. Cell. Mol. Med.202125209513952210.1111/jcmm.1689134464498
     [Google Scholar]
  79. HsuS.C. ChungJ.G. Anticancer potential of emodin.Biomedicine20122310811610.1016/j.biomed.2012.03.00332289000
     [Google Scholar]
  80. DiX. WangX. DiX. LiuY. Effect of piperine on the bioavailability and pharmacokinetics of emodin in rats.J. Pharm. Biomed. Anal.201511514414910.1016/j.jpba.2015.06.02726201645
     [Google Scholar]
  81. LiH. KrstinS. WangS. WinkM. Capsaicin and piperine can overcome multidrug resistance in cancer cells to doxorubicin.Molecules201823355710.3390/molecules2303055729498663
     [Google Scholar]
  82. GewirtzD. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin.Biochem. Pharmacol.199957772774110.1016/S0006‑2952(98)00307‑410075079
     [Google Scholar]
  83. FofariaN.M. KimS.H. SrivastavaS.K. Piperine causes G1 phase cell cycle arrest and apoptosis in melanoma cells through checkpoint kinase-1 activation.PLoS One201495e9429810.1371/journal.pone.009429824804719
     [Google Scholar]
  84. KapinovaA. StefanickaP. KubatkaP. Are plant-based functional foods better choices against cancer than single phytochemicals? A critical review of current breast cancer research.Biomed. Pharmacother.2017951465147710.1016/j.biopha.2017.11.13429198744
     [Google Scholar]
  85. NeyrinckA.M. AlligierM. MemvangaP.B. Curcuma longa extract associated with white pepper lessens high fat diet-induced inflammation in subcutaneous adipose tissue.PLoS One2013811e8125210.1371/journal.pone.008125224260564
     [Google Scholar]
  86. RatheeD. KambojA. SidhuS. Augmentation of hepatoprotective potential of aegle marmelos in combination with piperine in carbon tetrachloride model in wistar rats.Chem. Cent. J.20181219410.1186/s13065‑018‑0463‑930123925
     [Google Scholar]
  87. YingX. ChenX. ChengS. ShenY. PengL. XuH. Piperine inhibits IL-β induced expression of inflammatory mediators in human osteoarthritis chondrocyte.Int. Immunopharmacol.201317229329910.1016/j.intimp.2013.06.02523838114
     [Google Scholar]
  88. Abdel-DaimM.M. SayedA.A. AbdeenA. Piperine enhances the antioxidant and anti-inflammatory activities of thymoquinone against microcystin-l rinduced hepatotoxicity and neurotoxicity in mice.Oxid. Med. Cell. Longev.2019201911010.1155/2019/130917531178949
     [Google Scholar]
  89. KhatriS. AwasthiR. Piperine containing floating microspheres: An approach for drug targeting to the upper gastrointestinal tract.Drug Deliv. Transl. Res.20166329930710.1007/s13346‑016‑0285‑z26902907
     [Google Scholar]
  90. HiwaleA.R. DhuleyJ.N. NaikS.R. Effect of co-administration of piperine on pharmacokinetics of beta-lactam antibiotics in rats.Indian J. Exp. Biol.200240327728112635696
     [Google Scholar]
  91. JanakiramanK. ManavalanR. Studies on effect of piperine on oral bioavailability of ampicillin and norfloxacin.Afr. J. Tradit. Complement. Altern. Med.20085325726210.4314/ajtcam.v5i3.31281
     [Google Scholar]
  92. PanahiY. KhaliliN. HosseiniM.S. AbbasinazariM. SahebkarA. Lipid-modifying effects of adjunctive therapy with curcuminoids–piperine combination in patients with metabolic syndrome: Results of a randomized controlled trial.Complement. Ther. Med.201422585185710.1016/j.ctim.2014.07.00625440375
     [Google Scholar]
  93. SinghS. KumarP. Piperine in combination with quercetin halt 6-OHDA induced neurodegeneration in experimental rats: Biochemical and neurochemical evidences.Neurosci. Res.2018133384710.1016/j.neures.2017.10.00629056550
     [Google Scholar]
  94. SinghS. KumarP. Neuroprotective activity of curcumin in combination with piperine against quinolinic acid induced neurodegeneration in rats.Pharmacology2016973-415116010.1159/00044389626828892
     [Google Scholar]
  95. WardlawJ.M. MurrayV. BergeE. Recombinant tissue plasminogen activator for acute ischaemic stroke: An updated systematic review and meta-analysis.Lancet201237998342364237210.1016/S0140‑6736(12)60738‑722632907
     [Google Scholar]
  96. StrimpakosA.S. SharmaR.A. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials.Antioxid. Redox Signal.200810351154610.1089/ars.2007.176918370854
     [Google Scholar]
  97. Abdul ManapA.S. Tan WeiA.C. LeongW.H. Synergistic effects of curcumin and piperine as potent acetylcholine and amyloidogenic inhibitors with significant neuroprotective activity in sh-sy5y cells via computational molecular modeling and in vitro assay. front.Aging Neurosci20192711206
     [Google Scholar]
  98. BalakrishnanV. VarmaS. ChatterjiD. Piperine augments transcription inhibitory activity of rifampicin by severalfold in mycobacterium smegmatis.Curr. Sci.2001801013021305
     [Google Scholar]
  99. PatelS. DevadaS. PatelH. PatelN. BhavsarS. ThakerA. Influence of co-administration of piperine on pharmacokinetic profile of gatifloxacin in layer birds.Glob. Vet.201175427432
     [Google Scholar]
  100. JunsaengD. AnukunwithayaT. SongvutP. SritularakB. LikhitwitayawuidK. KhemawootP. Comparative pharmacokinetics of oxyresveratrol alone and in combination with piperine as a bioenhancer in rats.BMC Complement. Altern. Med.201919123510.1186/s12906‑019‑2653‑y31477089
     [Google Scholar]
  101. KrstinS. PeixotoH.S. WinkM. Combinations of alkaloids affecting different molecular targets with the saponin digitonin can synergistically enhance trypanocidal activity against trypanosoma brucei brucei.Antimicrob. Agents Chemother.201559117011701710.1128/AAC.01315‑1526349826
     [Google Scholar]
  102. RinwaP. KumarA. Piperine potentiates the protective effects of curcumin against chronic unpredictable stress-induced cognitive impairment and oxidative damage in mice.Brain Res.201214881488385010.1016/j.brainres.2012.10.00223099054
     [Google Scholar]
  103. MoorthiC. KrishnanK. ManavalanR. KathiresanK. Preparation and characterization of curcumin–piperine dual drug loaded nanoparticles.Asian Pac. J. Trop. Biomed.201221184184810.1016/S2221‑1691(12)60241‑X23569859
     [Google Scholar]
  104. TuY.S. FuJ.W. SunD.M. Preparation, characterisation and evaluation of curcumin with piperine-loaded cubosome nanoparticles.J. Microencapsul.201431655155910.3109/02652048.2014.88560724641575
     [Google Scholar]
  105. MgbeahuruikeE.E. StalnackeM. VuorelaH. HolmY. Antimicrobial and synergistic effects of commercial piperine and piper longum in combination with conventional antimicrobials.Antibiotics20198255
     [Google Scholar]
  106. Tokam KuatéC.R. Bisso NdezoB. DzoyemJ.P. Synergistic antibiofilm effect of thymol and piperine in combination with aminoglycosides antibiotics against four salmonella enterica serovars.Evid. Based Complement. Alternat. Med.2021156701710.1155/2021/1567017
     [Google Scholar]
  107. AthukuriB.L. NeeratiP. Enhanced oral bioavailability of domperidone with piperine in male wistar rats: involvement of CYP3A1 and P-gp inhibition.J. Pharm. Pharm. Sci.201720283710.18433/J3MK7228459658
     [Google Scholar]
  108. PattanaikS. HotaD. PrabhakarS. KharbandaP. PandhiP. Effect of piperine on the steady-state pharmacokinetics of phenytoin in patients with epilepsy. phyther res. an int. j. devoted to pharmacol toxicol eval.Nat Prod Deriv200620683686
     [Google Scholar]
  109. AutiP. ChoudharyA. GabheS. MahadikK. Bioanalytical method development, validation and its application in pharmacokinetic studies of verapamil in the presence of piperine in rats.Int J Pharm Res201810119
     [Google Scholar]
  110. BanoG. AmlaV. RainaR. ZutshiU. ChopraC. The effect of piperine on pharmacokinetics of phenytoin in healthy volunteers.Planta Med.198753656856910.1055/s‑2006‑9628143444866
     [Google Scholar]
  111. BedadaS.K. BogaP.K. The influence of piperine on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy volunteers.Eur. J. Clin. Pharmacol.201773334334910.1007/s00228‑016‑2173‑327981349
     [Google Scholar]
  112. AutiP. GabheS. MahadikK. Pharmacokinetic studies of secnidazole in the presence of piperine and its synthetic derivative.Int. J. Pharm. Sci. Res.201814551461
     [Google Scholar]
  113. ShobaG. JoyD. JosephT. MajeedM. RajendranR. SrinivasP. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers.Planta Med.199864435335610.1055/s‑2006‑9574509619120
     [Google Scholar]
  114. BanoG. RainaR.K. ZutshiU. BediK.L. JohriR.K. SharmaS.C. Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers.Eur. J. Clin. Pharmacol.199141661561710.1007/BF003149961815977
     [Google Scholar]
  115. Bisso NdezoB. Tokam KuatéC.R. DzoyemJ.P. Synergistic antibiofilm efficacy of thymol and piperine in combination with three aminoglycoside antibiotics against klebsiella pneumoniae biofilms.Can. J. Infect. Dis. Med. Microbiol.2021702994410.1155/2021/7029944
     [Google Scholar]
  116. MohanalakshmiS. BhattS. Ashok KumarC.K. Enhanced antihyperlipidemic potential of gemfibrozil under co-administration with piperine.BMC Complement. Altern. Med.202119123510.1016/j.crphar.2021.100021
     [Google Scholar]
  117. LiG. RuanL. ChenR. Synergistic antidepressant-like effect of ferulic acid in combination with piperine: Involvement of monoaminergic system.Metab. Brain Dis.20153061505151410.1007/s11011‑015‑9704‑y26220010
     [Google Scholar]
  118. HoffmanA DombJA ElgartA CherniakovI Formulation and method for increasing oral bioavailability of drugsPatent US20200009067A12020
  119. BhagatU. Optimized nutritional formulations, methods for selection of tailored diets therefrom, and methods of use thereof.Patent CA2814053C2012
  120. DiMauroMT Method of topically administering a curcumin derivative.Patent US20160374960A12016
  121. SezginCV BayraktarO Production of curcumin and piperine loaded double-layered biopolymer based nano delivery systems by using electrospray / coating method.Patent EP3142702B12018
  122. MajidM BadmaevV RagendranE. Piperine-containing composition.Patent JP3953513B2,2007
     [Google Scholar]
  123. JinglingT JinmeiR LinhuaW HongyuJ MengtingL ChaoC Carry solid lipid nanoparticle of curcumin and piperine and preparation method thereof.Patent CN103784421B2016
  124. Kapil SinghR. Pharmaceutical compositions containing piperine and an antituberculosis or antileprosydrug.Patent EP06507281995
  125. PatelB.R. ModiA.I. Compositions containing piperine.Patent US5616593,1997
  126. KhajuriaA. ThusuN. ZutshiU. Piperine modulates permeability characteristics of intestine by inducing alterations in membrane dynamics: Influence on brush border membrane fluidity, ultrastructure and enzyme kinetics.Phytomedicine20029322423110.1078/0944‑7113‑0011412046863
     [Google Scholar]
  127. VeerareddyP.R. VobalaboinaV. Pharmacokinetics and tissue distribution of piperine lipid nanospheres.Pharmazie200863535235518557418
     [Google Scholar]
  128. KaurJ. SinghR.R. KhanE. KumarA. JoshiA. Piperine-loaded PLGA nanoparticles as cancer drug carriers.ACS Appl. Nano Mater.2021412141971420710.1021/acsanm.1c03664
     [Google Scholar]
  129. AbouAitahK. StefanekA. HigazyI.M. Effective targeting of colon cancer cells with piperine natural anticancer prodrug using functionalized clusters of hydroxyapatite nanoparticles.Pharmaceutics20201217010.3390/pharmaceutics1201007031963155
     [Google Scholar]
  130. GuldikenB. OzkanG. CatalkayaG. CeylanF.D. Ekin YalcinkayaI. CapanogluE. Phytochemicals of herbs and spices: Health versus toxicological effects.Food Chem. Toxicol.2018119374910.1016/j.fct.2018.05.05029802945
     [Google Scholar]
  131. PiyachaturawatP. GlinsukonT. ToskulkaoC. Acute and subacute toxicity of piperine in mice, rats and hamsters.Toxicol. Lett.1983163-435135910.1016/0378‑4274(83)90198‑46857729
     [Google Scholar]
  132. ChonpathompikunlertP. YoshitomiT. HanJ. IsodaH. NagasakiY. The use of nitroxide radical-containing nanoparticles coupled with piperine to protect neuroblastoma SH-SY5Y cells from Aβ-induced oxidative stress.Biomaterials201132338605861210.1016/j.biomaterials.2011.07.02421855995
     [Google Scholar]
  133. DawareM. MujumdarA. GhaskadbiS. Reproductive toxicity of piperine in Swiss albino mice.Planta Med.200066323123610.1055/s‑2000‑856010821048
     [Google Scholar]
  134. KazmiI. Al-AbbasiF.A. ImamS.S. Formulation of piperine nanoparticles: In vitro breast cancer cell line and in vivo evaluation.Polymers2022147134910.3390/polym1407134935406223
     [Google Scholar]
/content/journals/cff/10.2174/2666862901666230727104158
Loading
Hand-in-glove Effect of Piperine in Anti-cancer Formulations
Curr Func Foods 2, E270723219193 (2024); https://doi.org/10.2174/2666862901666230727104158
/content/journals/cff/10.2174/2666862901666230727104158
/content/journals/cff/10.2174/2666862901666230727104158
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Bioavailability enhancer; cancer; combination; molecular targets; piperine; synergism

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test